FDA Global

Office of Global Policy and Strategy carries out FDA's global public health mission: overseeing foreign offices, trade policy, bilateral/multilateral relations.

[FDA Global @FDA_Global]

A new MRA milestone – FDA has completed capability assessments of veterinary authorities in the EU’s 27 Member States. Expanding the MRA to vet drugs means less duplication of inspections, saving resources for higher risk locations. https://t.co/TdrmdsfNvb

[FDA Office of Inspections and Investigations @FDAInspects]

Meet Imogene Gollinger, the FDA’s first woman field investigator. Her legacy highlights the power of resilience, adaptability, & the vital role of investigators in advancing the FDA’s mission. Her work continues to inspire today. https://t.co/4aL9iA9OMq.
#FDA #PublicHealth

[FDA Oncology @FDAOncology]

Healthcare Providers: Need help submitting Expanded Access requests for investigational cancer treatments for your patients? FDA’s Project Facilitate call and information center is here to assist! 🔗 Learn more: https://t.co/E0R4f0zQip

[U.S. FDA en Español @FDAenEspanol]

El subcomisionado @FDA_KyleD acaba de regresar de la Ciudad de México, donde sostuvo reuniones productivas con @SENASICA, @COFEPRIS y el equipo de la Oficina para América Latina de la FDA y reflexiona que todavía hay mucho por hacer y discutir sobre los objetivos compartidos para fortalecer la prevención a través de la Alianza para la Inocuidad Alimentaria entre EE. UU. y México, y garantizar que las familias puedan confiar que los alimentos en su esas son reales y frescos.

[Deputy Commissioner Kyle Diamantas @FDA_KyleD]

Productive meetings in Mexico City this week with @Agricultura_mex, @SENASICA, @COFEPRIS, and our @US_FDA Office of Latin America team. Discussed critical food safety priorities including Cyclospora prevention, agricultural water safety, and traceability for fresh produce. Ongoing partnership and collaboration are key to protecting public health across our borders and for ensuring safe, fresh produce for American families. #MAHA #foodsafety

[Deputy Commissioner Kyle Diamantas @FDA_KyleD]

Our bilateral conversations continue, this time in Berlin. @FDAFood leadership met with Germany’s Federal Office of Consumer Protection and Food Safety (@BVL_Bund) and the Federal Institute for Risk Assessment (@bfrde) to discuss food safety priorities, advances in data analytics, and opportunities to deepen our collaboration.

[U.S. FDA @US_FDA]

Check out the new “FDA At a Glance” report for this and other fascinating statistics! https://t.co/LdXLqZL1qg

[Deputy Commissioner Kyle Diamantas @FDA_KyleD]

Just wrapped a productive visit to Brussels meeting with @EU_Health Directorate-General for Health & Food Safety (SANTE) and industry stakeholders to discuss practical areas for bilateral collaboration. Strong partnerships help strengthen protections for consumers on both sides of the Atlantic.

[Deputy Commissioner Kyle Diamantas @FDA_KyleD]

Great meeting with @FoodDrinkEU to discuss @FDAfood priorities on nutrition and food safety, and to hear EU food industry perspectives about work in Europe to create a healthier food supply.

[FDA Global @FDA_Global]

Today, @US_FDA and the European Medicines Agency released 10 guiding principles to inform, enhance, and promote the use of artificial intelligence (AI) for generating evidence across all phases of the drug product life cycle. https://t.co/ZFqHXU8gt7

[Ambassador Sergio Gor @USAmbIndia]

Namaste! Today marks my first day at the U.S. Embassy in New Delhi. I am honored to join this dedicated team and eager to get to work advancing President Donald Trump’s priorities and deepening the U.S.-India partnership. I couldn’t be more optimistic about the days ahead for both of our nations under President Trump’s leadership. 🇺🇸🇮🇳

[FDA Global @FDA_Global]

FDA's latest From a Global Perspective is out. Read how Japan’s regulatory leaders are collaborating with the FDA & what they are doing to encourage global drug companies to market their new drug products in Japan. https://t.co/rpZC7quhad

[womenshealth.gov @womenshealth]

📣 New OWH publication: Check out this article, published in @BMC_series Pregnancy and Childbirth, which examines the severity of delivery-related #MaternalHealth outcomes & offers an improved metric that can help inform better care practices, policies, & support systems for pregnant women. Access here: https://t.co/mKtl2em3QM

[FDA Drug Information @FDA_Drug_Info]

FDA announces a public workshop on improving access to epinephrine for anaphylaxis treatment. Seeking input on barriers & solutions to reduce deaths from severe allergic reactions. Virtual event Dec 16. Register: https://t.co/eKcgiP2qTv #Anaphylaxis #PublicHealth

[FDA Oncology @FDAOncology]

Older adults face unique challenges in cancer care.

Join the #FDAOncology Conversations on Cancer discussion: “Empowered Choices: Perspectives on Cancer Care Decision-Making Among Older Adults.”

📅 Dec. 11, 2025 | 💻 Virtual event
https://t.co/LJd0bwXiKQ

[Indian Pharmaceutical Alliance @IPAOfficialPage]

Delivering the opening remarks of the 10th Advanced GMP Workshop 2025, Gregory Smith, Country Director of the @US_FDA India Office, underscored India’s vital role in strengthening global health systems. He highlighted how India’s scientific capability, manufacturing depth, and the largest pool of USFDA-approved sites worldwide position the country as an indispensable partner in advancing affordable, high-quality healthcare.

#IPA #AdvancedGMP #IndianPharma #GMP #USFDA #Quality #RegulatoryScience

[FDA Drug Information @FDA_Drug_Info]

#FDA approves a treatment for follicular lymphoma indications. [FDA approves epcoritamab-bysp for follicular lymphoma indications | FDA].

[FDA Drug Information @FDA_Drug_Info]

FDA published 76 new and revised product-specific guidances to improve access to safe, effective, & affordable medications. PSGs facilitate the timely development of high-quality generic drugs by bringing greater efficiency and transparency to the process.
https://t.co/oaWQlcscdq

[U.S. FDA @US_FDA]

🎤 SEE NOW: Principal Deputy Commissioner Sara Brenner's opening remarks from FDA’s meeting this week with @DukeMargolis. Hear the agency’s vision for advancing RWE in medical product development.
https://t.co/Q4iSWY0PT7

[FDA Drug Information @FDA_Drug_Info]

FDA eliminates special safety requirements (REMS) for Caprelsa cancer drug after >decade of successful monitoring. Health care providers now have adequate knowledge to safely manage heart rhythm related risks without mandatory protocols. #CancerTreatment
https://t.co/23n6Yx8AQt